Bleeding and Clotting Disorders Institute

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Haemophilia3 trials
• Immune thrombocytopenia (ITP)2 trials
• Sickle cell disease1 trial
• Thalassaemia1 trial

Phase

• Phase 22 trials
• Phase 1/21 trial

Status

• Active, not recruiting1 trial
• Completed1 trial
• Not yet recruiting1 trial
• Recruiting1 trial
• Terminated1 trial

Lead sponsor

• American Thrombosis and Hemostasis Network1 trial
• Eli Lilly and Company1 trial
• Sanofi1 trial
• Takeda1 trial
• University of Washington1 trial

Running trials

• Recruiting

  A Study of Pirtobrutinib in Participants With Immune Thrombocytopenia

  NCT06721013· Phase 1/2· Eli Lilly and Company· Source

• Active, not recruiting

  Emicizumab in Patients With Acquired Hemophilia A

  NCT05345197· Phase 2· University of Washington· Source

• Recruiting

  ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders

  NCT04398628· American Thrombosis and Hemostasis Network· Source

  Contact: Sarah Malik

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Haemophilia1 recruiting
• Immune thrombocytopenia (ITP)1 recruiting
• Sickle cell disease1 recruiting
• Thalassaemia1 recruiting

Closed trials

• Terminated

  Goal Attainment and Physical Activity in People With Hemophilia A

  NCT06530030· Sanofi· Source

• Completed

  A Study of TAK-079 in Adults With Persistent/Chronic Primary Immune Thrombocytopenia

  NCT04278924· Phase 2· Takeda· Source